By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
News Center

Press releases

Text Link

September 24, 2024

Results for the first half of 2024

(French only)
Text Link

August 2, 2024

Eurobio Scientific completes acquisition of Endopredict® genomic test from Myriad Genetics

(French only)
Text Link

August 1, 2024

Suspension of the liquidity contract (in french)

(French only)
Text Link

July 31, 2024

First half 2024, a solid start of the financial year in an uncertain environment - PROPOSED TENDER OFFER

(French only)
Text Link

May 7, 2024

Agreement to acquire the ENDOPREDICT gene expression test for breast cancer

(French only)
Text Link

April 26, 2024

Publication of the 2023 financial annual report (in french only)

(French only)
Text Link

April 9, 2024

2023 annual results, growth in Core Business and strategic deployment

(French only)
Text Link

January 30, 2024

2023 Annuel revenue at 130,1 MEUR

(French only)
Text Link

January 9, 2024

Capital reduction through cancellation of treasury shares

(French only)
Text Link

November 7, 2023

Catherine Courboillet to join the Board as an Independant Member

(French only)
Text Link

October 17, 2023

GenDx reduces organ matching time to 3 hours

(French only)
Text Link

October 11, 2023

H1 2023 Results: Solid performance of Core Business and acceleration of strategic deployment

(French only)
Text Link

July 24, 2023

Acceleration of strategic deployment in the first half of 2023

(French only)
Text Link

July 11, 2023

Capital reduction through cancellation of treasury shares

(French only)
Text Link

July 5, 2023

Half-year report on liquidity contract

(French only)
Text Link

June 16, 2023

All resolutions approved at the 2023 Annual General Meeting - The Board of Directors appoints a new governance

(French only)
Text Link

June 13, 2023

Acquisition of D.I.D. in Italy

(French only)
Text Link

May 23, 2023

First IVDR CE marking of PCR tests

(French only)
Text Link

April 28, 2023

Publication of the 2022 annual financial report

(French only)
Text Link

April 5, 2023

2022 annual results : very strong performance and strengthening of the Core Business

(French only)
Text Link

February 14, 2023

Wietse Mulder, CEO of GenDx, holds a 2% stake in Eurobio Scientific

(French only)
Text Link

February 8, 2023

Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO

(French only)
Text Link

January 23, 2023

2022 annual turnover of €152.5M

(French only)
Text Link

January 5, 2023

H2 2022 report on the liquidity contract

(French only)
Text Link

November 22, 2022

Exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer

(French only)
Text Link

October 27, 2022

Half-year financial report available

(French only)
Text Link

October 11, 2022

H1 2022 Results: continued growth of non-COVID activity

(French only)
Text Link

October 3, 2022

Eurobio Scientific finalizes the acquisition of GenDx, international HLA diagnostics specialist

(French only)
Text Link

August 17, 2022

Eurobio Scientific signs an agreement to acquire GenDx, international HLA diagnostics specialist

(French only)
Text Link

July 25, 2022

First half turnover of €83.6 million maintained at a high level

(French only)
Text Link

July 11, 2022

Half-year report on liquidity contract

(French only)
Text Link

June 20, 2022

Launch of 2 new proprietary tests : new variants of SARS-CoV-2, and Monkeypox

(French only)
Text Link

June 14, 2022

Eurobio Scientific's annual shareholders' meeting

(French only)
Text Link

June 13, 2022

Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV

(French only)
Text Link

May 18, 2022

Closing of the Strategic Partnership with NEXTSTAGE AM

(French only)
Text Link

April 26, 2022

Eurobio Scientific partners with Dr. Nino Guy Cassuto for the development of a new PCR test for male fertility

(French only)
Text Link

April 14, 2022

CE mark for Eurobio Scientific’s new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2

(French only)
Text Link

April 6, 2022

Maintaining high level results in 2021

(French only)
Text Link

March 10, 2022

New priority test for the detection of Omicron BA.x, BA.2 and Delta of SARS-CoV-2

(French only)
Text Link

February 7, 2022

Strategic partnership with NextStage AM

(French only)
Text Link

January 24, 2022

2021 TURNOVER : Exceptional level of €184.1million

(French only)
Text Link

January 11, 2022

Eurobio Scientific launches the exclusive distribution of the first saliva self-test for HIV testing in France

(French only)
Text Link

December 13, 2021

Eurobio Scientific obtains CE marking for its proprietary test for Covid-19 screening and detection of the Omicron and Delta variants

(French only)
Text Link

November 30, 2021

Omicron variant : Eurobio Scientific launches the first PCR test allowing simultaneous SARS-CoV-2 virus screening and detection of the Delta and Omicron variants in a single reaction

(French only)
Text Link

November 23, 2021

Eurobio Scientific makes a minority investment in Usense

(French only)
Text Link

October 12, 2021

2021 Half-year earnings : EBITDA up +110% to €42.5m

(French only)
Text Link

October 6, 2021

Eurobio Scientific receives a $430,000 milestone payment from Allergan

(French only)
Text Link

July 26, 2021

First half turnover reaches €95.7 million, a 54% increase

(French only)
Text Link

May 26, 2021

Eurobio Scientific launches a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations

(French only)
Text Link

April 29, 2021

Exceptional 2020 results

(French only)
Text Link

March 9, 2021

EUROBIO Scientific extends its family of proprietary PCR tests to allow the identification of SARS-CoV-2 variants

(French only)
Text Link

January 25, 2021

Exceptional 2020 turnover of € 189 million (+220%)

(French only)
Text Link

January 18, 2021

Eurobio Scientific expands its range of COVID-19 tests with an antigenic rapid test

(French only)
Text Link

October 15, 2020

2020 half-year results : EBITDA at €20.3 M

(French only)
Text Link

September 22, 2020

Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen

(French only)
Text Link

September 15, 2020

Eurobio Scientific announces the CE marking of its COVID EBX FluCoSyn™ PCR test

(French only)
Text Link

July 21, 2020

Very strong growth of business during the first half of 2020

(French only)
Text Link

July 15, 2020

Eurobio Scientific expands into Switzerland, Germany, Austria and Benelux with the acquisition of TECOmedical AG

(French only)
Text Link

June 9, 2020

CNR validation of two COVID-19 serology tests

(French only)
Text Link

May 13, 2020

Eurobio Scientific and the Hospices Civils de Lyon join forces to develop a bank of anti-SARS CoV-2 antibodies

(French only)
Text Link

May 11, 2020

Eurobio Scientific's proprietary PCR test confirmed as part of the fight against COVID-19

(French only)
Text Link

May 5, 2020

Eurobio Scientific and NG Biotech enter into a marketing agreement for COVID-19 serology rapid tests

(French only)
Text Link

April 14, 2020

Strong growth of 2019 annual results

(French only)
Text Link

March 31, 2020

Eurobio Scientific launches MagLumi COVID-19 automated test from its partner SNIBE for COVID-19 serology

(French only)
Text Link

March 25, 2020

Eurobio Scientific gets CE marking for its proprietary COVID-19 test

(French only)
Text Link

January 27, 2020

Eurobio Scientific anounced full-year revenues up 17% to €59.1M

(French only)
Text Link

November 4, 2019

Eurobio Scientific enters into a strategic agreement for the development of proprietary products in molecular biology

(French only)
Text Link

October 15, 2019

Strong Earnings Growth for the First Half of 2019

(French only)
Text Link

October 1, 2019

Eurobio Scientific joins the Enternext PEA PME 150 index

(French only)
Text Link

July 23, 2019

First Semester 2019 : strong growth of sales

(French only)
Text Link

June 12, 2019

Eurobio Scientific and Vivo Medical Group enter into exclusive negociations for the acquisition of two companies in the United Kingdom

(French only)
Text Link

April 17, 2019

Eurobio Scientific - 2018 annual results

(French only)
Text Link

January 29, 2019

Eurobio Scientific reaches the €50M sales mark in 2018

(French only)
Text Link

January 8, 2019

Eurobio Scientific announces its financial communication calendar for 2019

(French only)
Text Link

October 31, 2018

Lending of bond funds of €2.5M with Vatel Direct (French version)

(French only)
Text Link

October 23, 2018

EUROBIO SCIENTIFIC certified ISO 13485 V2016

(French only)